BIOVENTUS INC. - CLASS A COMMON STOCK

Dave Crawford Joins Bioventus as Vice President, Investor Relations and Treasurer

23 Aug 2021 08:30:00 By Nasdaq GlobeNewswire

Bioventus Reports Second Quarter Results; Updates Full Year 2021 Financial Guidance

10 Aug 2021 16:05:02 By Nasdaq GlobeNewswire

Bioventus and Misonix Announce Definitive Agreement for Bioventus to Acquire Misonix

29 Jul 2021 16:05:01 By Nasdaq GlobeNewswire

Bioventus Inc. Reports Preliminary Second Quarter Net Sales; Updates Full-Year 2021 Net Sales Guidance

29 Jul 2021 16:00:00 By Nasdaq GlobeNewswire

Bioventus® Management to Present at Canaccord Genuity Growth Conference and Morgan Stanley Virtual Global Healthcare Conference

27 Jul 2021 16:15:00 By Nasdaq GlobeNewswire

Bioventus Appoints Mary Kay Ladone to Board of Directors

14 Jul 2021 16:05:00 By Nasdaq GlobeNewswire

Bioventus Launches OSTEOAMP® SELECT Flowable Nationwide

13 Jul 2021 08:30:00 By Nasdaq GlobeNewswire

Bioventus Invests in Vaporox

24 Jun 2021 16:36:41 By Nasdaq GlobeNewswire

Bioventus to Release Second Quarter of Fiscal Year 2021 Financial Results on August 10, 2021

16 Jun 2021 16:05:00 By Nasdaq GlobeNewswire

Bioventus Study Shows Novel Placental Tissue Biologic Candidate Inhibited Inflammatory and Catabolic Responses In Vitro

25 May 2021 09:00:01 By Nasdaq GlobeNewswire

Bioventus Senior Management to Present at Upcoming Investor Conferences

17 May 2021 08:15:00 By Nasdaq GlobeNewswire

Bioventus Inc. Reports First Quarter Results; Updates Full Year 2021 Financial Guidance

12 May 2021 16:05:00 By Nasdaq GlobeNewswire

Bioventus Announces First Commercial Shipment of the Bioness® Integrated Therapy System (BITS) Balance System

27 Apr 2021 08:30:00 By Nasdaq GlobeNewswire